Early specialized palliative care for patients with metastatic lung cancer receiving chemotherapy : a feasibility study of a nurse-led screening-triggered programme

Article indépendant

MATSUMOTO, Yoshihisa | UMEMURA, Shigeki | OKIZAKI, Ayumi | FUJISAWA, Daisuke | KOBAYASHI, Naoko | TANAKA, Yuko | SASAKI, Chiyuki | SHIMIZU, Ken | OGAWA, Asao | KINOSHITA, Hiroya | UCHITOMI, Yosuke | YOSHIUCHI, Kazuhiro | MATSUYAMA, Yutaka | MORITA, Tatsuya | GOTO, Koichi | OHE, Yuichiro

BACKGROUND: Strategies to implement early specialized palliative care have not yet been established. The present study investigated the feasibility of a nurse-led, screening-triggered early specialized palliative care intervention programme and obtained data to design a randomized controlled trial. METHODS: Patients with metastatic lung cancer undergoing first-line platinum-based chemotherapy were eligible. The intervention consisted of (1) a questionnaire-based screening programme and (2) advanced-level nurse counselling and care coordination with interdisciplinary team approach. The primary endpoint was the completion rate of the assessment questionnaire after the second course of first-line chemotherapy (T2). Secondary endpoints included changes in Functional Assessment of Cancer Therapy-Lung scores, depression and anxiety rates based on the Patient Health Questionnaire 9 and the Hospital Anxiety and Depression Scale, and the contents of specialized palliative care. RESULTS: A total of 50 patients were enrolled between August 2012 and March 2014. Median age was 66 years (range, 40-78 year) and 84% were male. A total of 38 patients had stage IV non-small cell lung carcinoma and 12 had extensive disease small-cell lung carcinoma. The completion rate was 70% (95% confidence interval 56.0-81.0). The median duration between baseline and T2 was 53 days. Improvement from baseline were observed at T2 in Functional Assessment of Cancer Therapy-Lung scores (86.0 ± 18.1 vs 94.9 ± 18.2, P = 0.057), depression (16.0 vs 5.7%; P = 0.26) and anxiety (32.0 vs 22.9%; P = 0.65); however, these results were not statistically significant. CONCLUSIONS: This early specialized palliative care intervention is feasible and could be useful in improving patients' quality of life. The present results justify the initiation of a randomized control trial.

http://dx.doi.org/10.1093/jjco/hyab204

Voir la revue «Japanese journal of clinical oncology, 52»

Autres numéros de la revue «Japanese journal of clinical oncology»

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Gestion